Cochrane Abstracts
Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia: Cochrane systematic review
Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Naloxone for Preventing Morbidity and Mortality in Newborn Infants of Greater Than 34 Weeks' Gestation With Suspected Perinatal Asphyxia: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433624/all/Naloxone_for_preventing_morbidity_and_mortality_in_newborn_infants_of_greater_than_34_weeks'_gestation_with_suspected_perinatal_asphyxia:_Cochrane_systematic_review. Accessed 28 July 2021.
Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433624/all/Naloxone_for_preventing_morbidity_and_mortality_in_newborn_infants_of_greater_than_34_weeks'_gestation_with_suspected_perinatal_asphyxia:_Cochrane_systematic_review. Accessed July 28, 2021.
Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433624/all/Naloxone_for_preventing_morbidity_and_mortality_in_newborn_infants_of_greater_than_34_weeks'_gestation_with_suspected_perinatal_asphyxia:_Cochrane_systematic_review
Naloxone for Preventing Morbidity and Mortality in Newborn Infants of Greater Than 34 Weeks' Gestation With Suspected Perinatal Asphyxia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2021 July 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433624/all/Naloxone_for_preventing_morbidity_and_mortality_in_newborn_infants_of_greater_than_34_weeks'_gestation_with_suspected_perinatal_asphyxia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia: Cochrane systematic review
ID - 433624
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433624/all/Naloxone_for_preventing_morbidity_and_mortality_in_newborn_infants_of_greater_than_34_weeks'_gestation_with_suspected_perinatal_asphyxia:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
